Read news on HIV prevention with our app.
Read more in the app
<em>Science</em>’s 2024 Breakthrough of the Year: Opening the door to a new era of HIV prevention
Clinical trial reveals twice-yearly injection to be 96% effective in HIV prevention
Clinical trial at Emory University reveals twice-yearly injection to be 96% effective in HIV prevention - EurekAlert
NIH trial of rectal microbicide for HIV prevention begins in the United States - EurekAlert
Landmark trial may herald new era in HIV prevention
HIV prevention may only require two injections per year
Long-acting injectable cabotegravir for HIV prevention is safe in pregnancy, study finds
Long-acting injectable cabotegravir for HIV prevention is safe in pregnancy - EurekAlert
